3[1]ISIS2(Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous steptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction, ISIS-2 . Lancet, 1998,2:349-360.
4[2]Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and in high-risk patients. Antirombotic Trialists' Collaboration. BMJ, 2002,324:71-86.
5[3]Hayden M, Pignone M, Phililips C, et al. Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the U S. Preventive Services Task Force. Ann Intern Med, 2002,136:161-172.
6[4]Lancaster G I, Lancaster C J, Radley D, et al. Prior aspirin use in unstable angina predisposes to higher risk:The aspirin padadox. Int J Cardiol, 2001, 80:201-207.
7[5]Brouwer M A, Verheugt F W A. Oral anticoagulation for coronary syndromes. Circulation, 2002, 105:1270-1274.
8[6]The Organization to Assess Strategies for Ischaemic Syndromes(OASIS-2) Investigators. Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. J Am Coll Cardiol, 2001, 37:475-484.
9[7]Steinhulb S R, Balog C, Topol E J. Pretreatment with ticlopidine prior to stenting is associated with a substantial decrease in complications:Data from the EPISTENT trial(abstr 3061). Circulation, 1998, 98(17 Suppl):Ⅰ-573.
10[8]The Clopidogrel In Unstable Anginq To Prevent Recurrent Events Trial Investigators. The clopidogrel in unstable angina to prevent recurrent events trial Investigators: Effects of Clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001, 345:494-502.
